Tykhe Corp

PINK:HALB USA Biotechnology
Market Cap
$1.49 Million
Market Cap Rank
#50626 Global
#15479 in USA
Share Price
$0.00
Change (1 day)
-4.55%
52-Week Range
$0.00 - $0.00
All Time High
$0.08
About

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Tykhe Corp (HALB) - Total Assets

Latest total assets as of October 2025: $4.30K USD

Based on the latest financial reports, Tykhe Corp (HALB) holds total assets worth $4.30K USD as of October 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Tykhe Corp - Total Assets Trend (2008–2025)

This chart illustrates how Tykhe Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Tykhe Corp - Asset Composition Analysis

Current Asset Composition (July 2025)

Tykhe Corp's total assets of $4.30K consist of 40.8% current assets and 59.2% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 0.0%
Accounts Receivable $0.00 0.0%
Inventory $0.00 0.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $0.00 0.0%
Goodwill $0.00 0.0%

Asset Composition Trend (2008–2025)

This chart illustrates how Tykhe Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Tykhe Corp's current assets represent 40.8% of total assets in 2025, an increase from 0.4% in 2008.
  • Cash Position: Cash and equivalents constituted 0.0% of total assets in 2025, down from 0.4% in 2008.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 2.0% in 2008.
  • Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.

Tykhe Corp Competitors by Total Assets

Key competitors of Tykhe Corp based on total assets are shown below.

Company Country Total Assets
MedPacto Inc
KQ:235980
Korea ₩51.58 Billion
2H0
F:2H0
Germany €15.27 Million
Shenzhen CAU Technology Co Ltd
SHE:000004
China CN¥260.55 Million
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
China CN¥9.58 Billion
Nanhua Bio Medicine Co Ltd
SHE:000504
China CN¥841.96 Million
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
China CN¥509.14 Million
Chengzhi Shareholding Co Ltd
SHE:000990
China CN¥27.52 Billion
Hualan Biological EngineeringInc
SHE:002007
China CN¥16.27 Billion

Tykhe Corp - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.02 - 0.68

Lower asset utilization - Tykhe Corp generates 0.10x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -9505.32% - 152.88%

Negative ROA - Tykhe Corp is currently not profitable relative to its asset base.

Tykhe Corp - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.00 0.01 0.17
Quick Ratio 0.00 0.01 0.11
Cash Ratio 0.00 0.00 0.00
Working Capital $-702.20K $ -753.42K $ -1.20 Million

Tykhe Corp - Advanced Valuation Insights

This section examines the relationship between Tykhe Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 16.90
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) -55.7%
Total Assets $4.49K
Market Capitalization $20.80 USD

Valuation Analysis

Below Book Valuation: The market values Tykhe Corp's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Tykhe Corp's assets decreased by 55.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Tykhe Corp (2008–2025)

The table below shows the annual total assets of Tykhe Corp from 2008 to 2025.

Year Total Assets Change
2025-07-31 $4.49K -55.72%
2024-07-31 $10.13K -17.51%
2023-07-31 $12.28K -28.15%
2022-07-31 $17.09K -73.02%
2021-07-31 $63.35K +1361.07%
2020-07-31 $4.34K -98.97%
2017-07-31 $419.45K -29.93%
2016-07-31 $598.61K +406.13%
2011-07-31 $118.27K +17.19%
2010-07-31 $100.92K +0.41%
2009-07-31 $100.51K -70.59%
2008-07-31 $341.71K --